Talis Biomedical (TLIS)
US Market

Talis Biomedical (TLIS) Balance Sheet


Talis Biomedical Balance Sheet

Talis Biomedical's total assets for Q3 2023 were $107.23M, a decrease of -12.88% from the previous quarter. TLIS total liabilities were $25.67M for the fiscal quarter, a -4.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 169.29M$ 265.83M$ 198.41M$ 25.73M$ 11.38M
Total Liabilities
$ 42.55M$ 31.85M$ 306.98M$ 46.87M$ 63.38M
Total Equity Gross Minority
$ 126.74M$ 233.98M$ -108.57M$ -21.14M$ -52.00M
Total Capitalization
$ 126.74M$ 233.98M$ -108.57M$ -21.14M$ -52.00M
Preferred Stock Equity
Capital Lease Obligations
--$ 693.00K$ 0.00-
Currency in USD

Talis Biomedical Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis